These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21567323)

  • 21. Gram-negative outer and inner membrane models: insertion of cyclic cationic lipopeptides.
    Clausell A; Garcia-Subirats M; Pujol M; Busquets MA; Rabanal F; Cajal Y
    J Phys Chem B; 2007 Jan; 111(3):551-63. PubMed ID: 17228913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LpxC inhibitors: a patent review (2010-2016).
    Kalinin DV; Holl R
    Expert Opin Ther Pat; 2017 Nov; 27(11):1227-1250. PubMed ID: 28742403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid-mediated resistance of Gram-negative bacteria against various pore-forming antimicrobial peptides.
    Gutsmann T; Hagge SO; David A; Roes S; Böhling A; Hammer MU; Seydel U
    J Endotoxin Res; 2005; 11(3):167-73. PubMed ID: 15949145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of a carbohydrate-derived hydroxamic acid inhibitor of the bacterial enzyme (LpxC) involved in lipid A biosynthesis.
    Li X; Uchiyama T; Raetz CR; Hindsgaul O
    Org Lett; 2003 Feb; 5(4):539-41. PubMed ID: 12583763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An in vitro screen of bacterial lipopolysaccharide biosynthetic enzymes identifies an inhibitor of ADP-heptose biosynthesis.
    De Leon GP; Elowe NH; Koteva KP; Valvano MA; Wright GD
    Chem Biol; 2006 Apr; 13(4):437-41. PubMed ID: 16632256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Essential Membrane Protein Modulates the Proteolysis of LpxC to Control Lipopolysaccharide Synthesis in Escherichia coli.
    Fivenson EM; Bernhardt TG
    mBio; 2020 May; 11(3):. PubMed ID: 32430473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of action of bactericidal/permeability-increasing protein BPI on reconstituted outer membranes of gram-negative bacteria.
    Wiese A; Brandenburg K; Carroll SF; Rietschel ET; Seydel U
    Biochemistry; 1997 Aug; 36(33):10311-9. PubMed ID: 9254630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibacterial agents that inhibit lipid A biosynthesis.
    Onishi HR; Pelak BA; Gerckens LS; Silver LL; Kahan FM; Chen MH; Patchett AA; Galloway SM; Hyland SA; Anderson MS; Raetz CR
    Science; 1996 Nov; 274(5289):980-2. PubMed ID: 8875939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystal structure of LpxC, a zinc-dependent deacetylase essential for endotoxin biosynthesis.
    Whittington DA; Rusche KM; Shin H; Fierke CA; Christianson DW
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8146-50. PubMed ID: 12819349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The properties of the outer membrane localized Lipid A transporter LptD.
    Haarmann R; Ibrahim M; Stevanovic M; Bredemeier R; Schleiff E
    J Phys Condens Matter; 2010 Nov; 22(45):454124. PubMed ID: 21339611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A model for the proteolytic regulation of LpxC in the lipopolysaccharide pathway of Escherichia coli.
    Emiola A; Falcarin P; Tocher J; George J
    Comput Biol Chem; 2013 Dec; 47():1-7. PubMed ID: 23831517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistance to polymyxins: Mechanisms, frequency and treatment options.
    Falagas ME; Rafailidis PI; Matthaiou DK
    Drug Resist Updat; 2010; 13(4-5):132-8. PubMed ID: 20843473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A fluorescence-based homogeneous assay for measuring activity of UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase.
    Wang W; Maniar M; Jain R; Jacobs J; Trias J; Yuan Z
    Anal Biochem; 2001 Mar; 290(2):338-46. PubMed ID: 11237337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of the outer membrane of Gram-negative bacteria in antibiotic resistance: Ajax' shield or Achilles' heel?
    Page MG
    Handb Exp Pharmacol; 2012; (211):67-86. PubMed ID: 23090596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biogenesis of the Gram-negative bacterial outer membrane.
    Bos MP; Tommassen J
    Curr Opin Microbiol; 2004 Dec; 7(6):610-6. PubMed ID: 15556033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Towards antibacterial strategies: studies on the mechanisms of interaction between antibacterial peptides and model membranes.
    Wiese A; Gutsmann T; Seydel U
    J Endotoxin Res; 2003; 9(2):67-84. PubMed ID: 12803879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipopolysaccharide as a target for the development of novel therapeutics in gram-negative bacteria.
    Yethon JA; Whitfield C
    Curr Drug Targets Infect Disord; 2001 Aug; 1(2):91-106. PubMed ID: 12455407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enzymes of lipid A biosynthesis: targets for the design of new antibiotics.
    Raetz CR
    Prog Clin Biol Res; 1998; 397():1-14. PubMed ID: 9575543
    [No Abstract]   [Full Text] [Related]  

  • 40. [Generation and characterization of avian vitelline antibodies against lipopolysaccharide and lipid A. 2. Investigations of specificity of egg yolk antibodies (IgY) against endotoxin].
    Sasse M; Hlinak A
    Berl Munch Tierarztl Wochenschr; 1998 Apr; 111(4):127-33. PubMed ID: 9581346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.